Angiotensin I-converting enzyme gene insertion/deletion and angiotensinogen M235T polymorphisms: Risk of chronic renal failure

Kidney International

Volumn 58, Issue 2, 2000, Pages 513-519

  Gumprecht, J ^a   Zychma, M J ^a   Grzeszczak, W ^a   Zukowska Szczechowska, E ^a   Trautsolt, W ^a   Gorczynska, S ^a   Szydlowska, I ^a   Gawlik, B ^a   Rutkowski, B ^a   Rutkowski, P ^a   Klinger, M ^a   Zwolinska, D ^a   Smolenski, O ^a   Baczynski, R ^a   Drabczyk, R ^a   Szprynger, K ^a  

^a Dept/Clin Internal Med/Diabetol   (Poland)

Author keywords

End stage renal disease; Gene polymorphism; Heredity; Progressive kidney disease; Renin angiotensin system

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSINOGEN; ANTIHYPERTENSIVE AGENT; CHYMASE; DIPEPTIDYL CARBOXYPEPTIDASE; DNA; RENIN;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CHILD; CHRONIC KIDNEY FAILURE; DIABETIC NEPHROPATHY; DIALYSIS; FEMALE; GENE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK;

EID: 0033854243     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00197.x     Document Type: Article

References (39)

1. Kidney disease in the first-degree relatives of African-Americans with hypertensive end-stage renal disease
2. Familial, hemodynamic and metabolic factors in the predisposition to diabetic kidney disease
3. A familial risk of chronic renal failure among blacks on dialysis?
4. The role of genetic factors in the development of end-stage renal disease
5. Family history of end-stage renal disease among incident dialysis patients
6. Familial risk, age at onset, and cause of end-stage renal disease in white Americans
7. Race, socioeconomic status and the development of end-stage renal disease
8. Polymorphisms of the renin-angiotensin system genes in progressive renal disease
9. The role of angiotensin I-converting enzyme gene polymorphism in renal disease
10. Genetics of the renin-angiotensin system and renal disease: A progress report
11. Insertion/deletion polymorphism in ACE gene as a predictor for progression of diabetic nephropathy
12. Association between the angiotensin-converting enzyme insertion/deletion polymorphism and diabetic nephropathy: A methodological appraisal and systematic review
13. Angiotensin II causes mesangial cell hypertrophy
14. The intrarenal renin-angiotensin system
15. Role of the renin-angiotensin-aldosterone system in the progression of renal disease: A critical review
16. Molecular mechanisms of angiotensin II in the kidney: Emerging role in the progression of renal disease: Beyond haemodynamics
17. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM)
18. The TDT and other family-based tests for linkage disequilibrium and association
19. Polymorphisms in the genes encoding for human kinin receptors and the risk of the end-stage renal failure: Results of transmission/disequilibrium test
20. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels
21. Angiotensinogen polymorphism M235T, hypertension, and nephropathy in insulin-dependent diabetes
22. Angiotensin-converting enzyme and heart chymase gene polymorphism in hypertrophic cardiomyopathy
23. Ddel polymorphism in the AGTR1 gene
24. Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells
25. The role of angiotensin II in renal growth
26. EGF-induced mitogenesis in proximal tubular cells: Potentiation by angiotensin II
27. Pathophysiology of chronic tubulointerstitial disease in rats: Interactions of dietary acid load, ammonia, and complement component C3
28. Angiotensin converting enzyme gene polymorphism: Potential silencer motif and impact on progression in IgA nephropathy
29. Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy
30. No association of converting enzyme insertion/deletion polymorphism with immunoglobin A glomerulonephritis
31. Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy
32. Polymorphism of the angiotensin converting enzyme gene and clinical aspects of IgA nephropathy
33. The role of genetic polymorphisms of angiotensin-converting enzyme in the progression of renal diseases
34. Angiotensinogen gene polymorphisms in IDDM patients with diabetic nephropathy
35. The diabetic nephropathy study group: Angiotensinogen gene M235T polymorphism is not associated with diabetic nephropathy
36. A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM
37. Diabetic nephropathy is associated with AGT polymorphism T235: Results of a family-based study
38. Gender-specific association of M235T polymorphism in angiotensinogen gene and diabetic nephropathy in NIDDM
39. Pathways for angiotensin II generation in intact human tissue: Evidence from comparative pharmacological interruption of the renin system